Jing Li

Jing Li is an accomplished professional in the field of clinical pharmacology and pharmacometrics, currently serving as Executive Director at Exelixis since July 2020. Prior experience includes leadership roles at MedImmune from October 2012 to July 2020, where Jing held titles such as Director of Clinical Pharmacology, Pharmacometrics and DMPK, as well as Principal Clinical Pharmacokineticist. Before that, a position as Scientist and Associate Scientist was held at Genentech from February 2005 to October 2012. Jing Li earned a Ph.D. in Pharmaceutical Sciences from the University of Nebraska Medical Center (2000-2005) and a Bachelor of Science in Pharmaceutical Sciences from West China University of Medical Sciences (1994-1998).